换一批
换一批Hypoxia-inducible factor-1 {alpha} expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗体, 单克隆(Antibodies, Monoclonal);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);队列研究(Cohort Studies);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);女(雌)性(Female);随访研究(Follow-Up Studies);基因表达谱(Gene Expression Profiling);人类(Humans);缺氧诱导因子1, α亚基(Hypoxia-Inducible Factor 1, alpha Subunit);免疫酶技术(Immunoenzyme Techniques);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);泼尼松(Prednisone);预后(Prognosis);回顾性研究(Retrospective Studies);存活率(Survival Rate);组织阵列分析(Tissue Array Analysis);治疗结果(Treatment Outcome);长春新碱(Vincristine);青年人(Young Adult)
DOI
10.1200/JCO.2009.24.1893
PMID
20048181
发布时间
2021-10-20
- 浏览33
Journal of clinical oncology
1017-24页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
